Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04249479
Other study ID # NL68789.068.19
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date February 3, 2020
Est. completion date August 24, 2020

Study information

Verified date March 2021
Source Maastricht University Medical Center
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Abdominal computed tomographic (CT) is an important prognostic tool with regard to the detection of oncological, infectious and other abdominal disorders. The total iodine load (TIL) is regarded as a decisive factor in the opacification of parenchymal structures. The EICAR trial demonstrated that injection with high flow rates of prewarmed contrast media (CM) was safe and patients did not experience any pain, stress of discomfort during injection. Flow rates as high as 8.8 ml/s were injected without any discomfort. All concentrations used (e.g. 240, 300 and 370 mg I/ml) in this study were prewarmed. According to the recent recommendations (ESUR guidelines 10.0) it should be considered to warm iodine-based CM before administration. The hypothesis is that although using CM at room temperature (~23°C [~73°F]) might result in lower attenuation of the liver parenchyma than would be achieved using CM pre-warmed to body temperature, diagnostic image quality, patient safety and comfort will not be compromised by not pre-warming CM in this setting. According to the guidelines, it is regarded as best clinical practice to pre-warm CM. Surprisingly, these recommendations are merely based on a hypothetical assumption. In the literature, there are no studies evaluating this topic and it has never been clearly shown to result in a better patient comfort. For this reason, many clinics do not pre-warm their CM in daily clinical routine. Only one study evaluated subjective comfort in hysterosalpingography (HSG), in which CM is injected in to the cavity of the uterus. This study found that prewarmed CM alleviates the pain and decreased the incidence of vasovagal episodes during HSG. To the best of our knowledge, no study showed that prewarmed CM in CT resulted in higher patient comfort, in comparison to CM at room temperature (20° C). Up till now, all CM in the department is prewarmed. In case this study does not show a difference in patient comfort, prewarming the CM can be stopped, resulting in a considerable simplified workflow. The hypothesis is that usage of CM at room temperature (20° C) might result in a decreased level of patient comfort in abdominal CT, in comparison to pre-heated (37° C) CM, with no significant difference in diagnostic attenuation of the liver parenchyma between groups.


Description:

Abdominal computed tomography (CT) scans are performed daily on a regular basis. Since its advent, rapid technical advances in CT continuously improved image quality. Besides scan technique, the contrast media (CM) injection protocol is the crucial factor in abdominal imaging. Parenchymal contrast enhancement is determined by patient related factors (e.g. cardiac output, blood volume and patient weight), the CM injection protocol and the scan protocol. Much literature has been performed with regard to optimizing CM application and the scan protocol. Flow rate of the CM and patient discomfort have been thoroughly investigated in our department. Heating CM up to body temperature has been daily clinical routine in our department for years. According to the recent recommendations (ESUR guidelines 10.0) it is advised to warm iodine-based CM before administration. Warming the CM is expected to result in a higher patient comfort, based on clinical observation. Kok et al. showed in phantom experiments that high temperature, low iodine concentration and low viscosity significantly decreases injection pressure. Subsequently, as increased temperature reduces the viscosity of the CM, the decreased viscosity is hypothesized to reduce the risk of extravasation. A decreased viscosity might also have a substantial impact on individual tailored CM injection protocols in daily routine scanning as it is speculated that a decrease of viscosity and subsequent decrease in peak injection pressure could influence patient comfort during injection. The EICAR trial showed that prewarmed CM can be safely injected at high flow rates, without patient discomfort, pain or stress. However, the latter was not compared to CM at room temperature. Different CM concentrations are used in different hospitals throughout the world. The higher the concentration, the higher the viscosity of the CM. In present study, only one CM concentrations (e.g. 300 mg/ml) will be used, which is used in daily clinical practice for years. Heating the CM decreases the viscosity. It is therefore expected that the preheated CM in a concentration of 300 mg/ml has a lower viscosity in comparison to the CM at 20° C. Pre-warming CM might be regarded as best clinical practice. No studies have been performed to investigate this statement, nor is there any literature that shows that prewarmed CM has a favorable patient comfort compared to CM injected at room temperature. For these reasons, there remains to be some reluctance and many clinics still not pre-warm their CM. One study, in which CM is injected in to the cavity of the uterus to check for any anatomical variants and causes for infertility, showed a preference for prewarmed CM in hysterosalpingography (HCG). This study found that prewarmed CM alleviates the pain and decreased the incidence of vasovagal episode during the HCG. The hypothesis is that although using CM at room temperature (~23°C [~73°F]) might result in lower attenuation of the liver parenchyma than would be achieved using CM pre-warmed to body temperature, diagnostic image quality, patient safety and comfort will not be compromised by not pre-warming CM in this setting. Pre-warming CM requires special equipment and more complex planning and logistics. On the other hand, pre-warming CM may yield higher attenuation levels, comfort and image quality. In case this study does not show a significant difference in patient comfort and diagnostic quality between groups, pre-warming the CM can be stopped, resulting in a considerable simplified workflow.


Recruitment information / eligibility

Status Completed
Enrollment 218
Est. completion date August 24, 2020
Est. primary completion date August 24, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion criteria - Patients referred for abdominal CT - Patient = 18 years old and competent to sign informed consent Exclusion criteria - Hemodynamic instability - Pregnancy - Renal insufficiency defined as glomerular filtration rate (GFR) < 30ml/min/1.73m2 (Odin protocol 004720) - Iodine allergy (Odin protocol 022199) - Age < 18 year - Unable to give informed consent or no informed consent obtained - Inability to position an 18 gauge cannula in an antecubital vein

Study Design


Related Conditions & MeSH terms


Intervention

Other:
CM Temperature (20° C)
CM will be administered at 20° C (room temperature).
CM Temperature (37° C)
CM will be administered at 37° C (pre-heated).
Weight
The patients' weight is measured prior to scanning by a technician on a weighing scale available in the scanner room.

Locations

Country Name City State
Netherlands MaastrichtUMC Maastricht Limburg

Sponsors (1)

Lead Sponsor Collaborator
Maastricht University Medical Center

Country where clinical trial is conducted

Netherlands, 

Outcome

Type Measure Description Time frame Safety issue
Primary Liver attenuation Mean attenuation in Hounsfield Units (HU) is based on three liver segments, preferably segments 2, 5 and 8 (Couinaud classification). Absolute difference in mean attenuation of the liver parenchyma between groups was calculated with a two-sided 95% confidence interval of the difference. Expected within one month after the CT is performed
Secondary Patient comfort Patient (dis)comfort during and after injection of CM with varying temperatures, rated on a questionnaire Immediately after CT
Secondary Pain during injection Assessed with a questionnaire with the option yes/no Questionnaire immediately after CT
Secondary Pain rate Assessed with a 11-point numeric rating scale (0=no pain; 10=very severe pain) Questionnaire immediately after CT
Secondary Different physiological reactions and sensations injection Questionnaire has to be filled in which people can tick a box if they had feelings of shivering/goosebumps/or being cold. There is some free space to write down other sensations. Immediately after the CT
Secondary Objective image quality - Signal-to-noise ratio mean attenuation of the liver divided by the mean standard deviation Within one month after the CT is performed
Secondary Objective image quality - Contrast-to-noise ratio Mean liver attenuation minus HU of the left paraspinal muscle, divided by the SD of the attenuation of the paraspinal muscle Within one month after the CT is performed
Secondary Subjective image quality Rated in consensus on a 5-point Likert scale by two readers Within one month after the end of the study
Secondary Body weight Weight is measured on a weighing scale Right before the scan is performed
Secondary CM volume The milliliter of CM administered Information is expected to be collected from the Certegra form available in Impax within 1 month
Secondary Flow rate Flow rate of the contrast media in ml/s Information is expected to be collected from the Certegra form available in Impax within 1 month
Secondary Injection site Injection site of the CM Information is expected to be collected from the Certegra form available in Impax within 1 month
Secondary Catheter Gauge Catheter size used for CM injection Information is expected to be collected from the Certegra form available in Impax within 1 month
Secondary Effective milliamperes (mAs) The effective mAs used in the specific patient Information is expected to be collected from the Certegra form available in Impax within 1 month
Secondary CT Dose Index (CTDI)vol CTDIvol (in mGy) the patient received Information is expected to be collected from Impax within 1 month
Secondary Dose-length product (DLP) DLP (in mGycm) the patient received Information is expected to be collected from Impax within 1 month
Secondary Tube voltage Tube voltage used in the specific scan Information is expected to be collected from Impax within 1 month
See also
  Status Clinical Trial Phase
Not yet recruiting NCT04337229 - Evaluation of Comfort Behavior Levels of Newborns With Artificial Intelligence Techniques N/A
Completed NCT01951703 - Senofilcon A Investigational Manufacturing Process N/A
Completed NCT06380933 - The Effects of Receiving Warm Footbath With Lavender Essential Oil on Sleep and Comfort N/A
Completed NCT05546216 - Determination of the Effect of Raised Supine Position and Back Support on Back Pain, Anxiety and Comfort Level in Coronary Angiography Patients N/A
Not yet recruiting NCT06071169 - The Effect of Progressive Relaxation Exercise on Nurses N/A
Completed NCT05771870 - Pediatric Nursing Students' Self-efficacy Regarding Pediatric Medication Administration and, Clinical Comfort and Worry: A Study on a Two-group Pre-post-test Design Comparing Nurse and Peer Mentoring N/A
Completed NCT05081856 - Use Modular Medical Equipment Vehicle in Mobilization of Patient With Chest Tube N/A
Completed NCT06458608 - Hemodiasis Patients Using Virtual Reality Video N/A
Recruiting NCT05892679 - The Effect of Acupressure in Hemodialysis Patients N/A
Recruiting NCT06462690 - EFFECT OF CARE PROVIDED THROUGH SKIN CARE PROTOCOL ON ELDERLY PATIENTS N/A
Completed NCT04457921 - Deep Tissue Massage on Pain and Comfort After Cesarean N/A
Completed NCT05442619 - Developing a Portable Therapeutic Baby Nest for Newborns and Evaluation During Venous Blood Collection N/A
Completed NCT05759169 - The Effect of Foot Bath on Comfort, Fatigue, and Dialysis Symptoms N/A
Completed NCT05264844 - Peripheral Venous Catheter and Masking Tape N/A
Not yet recruiting NCT05434364 - Comparison Three Methods on Endotracheal Aspiration in Preterm Infants N/A
Completed NCT05756465 - The Effect of Smartphone-Based Virtual Reality Relaxation (S-VR) in Cancer Patients Undergoing Chemotherapy N/A
Not yet recruiting NCT04305990 - Demand-Driven Method for Gas Delivery in a Dental Setting N/A
Completed NCT00659815 - Performance of Bausch & Lomb ReNu MultiPlus Multi-Purpose Solution in a New Packaging Configuration N/A
Completed NCT06222047 - Pain and Comfort Level During Orogastric Catheter Insertion in Preterms N/A
Completed NCT02082158 - Assessment of Novel Respiratory Protective Devices in Healthcare N/A